Stay updated on Pembrolizumab in Unresectable Squamous Skin Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Unresectable Squamous Skin Cancer Clinical Trial page.

Latest updates to the Pembrolizumab in Unresectable Squamous Skin Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedRevision badge updated from v3.6.4 to v3.6.5, reflecting a minor deployment change. The study details themselves remain unchanged.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedRevision: v3.6.4 replaces the previous Revision: v3.6.3, signaling a minor update to the page template or content. It does not alter the study details or other user-facing information on the page.SummaryDifference0.1%

- Check52 days agoChange DetectedA new Revision: v3.6.3 label was added to the page, replacing the previous v3.6.2 label.SummaryDifference0.1%

- Check60 days agoChange DetectedThe page now shows Revision: v3.6.2, replacing the previous v3.6.0 label. This indicates a new deployment of the page without changes to study data.SummaryDifference0.1%

- Check74 days agoChange DetectedThe study page now displays that recruitment has ended, and new sections for How to Read a Study Record, Common Questions, and How to Join a Study have been added. Additionally, the label formatting for Intervention/Treatment was adjusted and the Revision tag updated to v3.6.0.SummaryDifference0.5%

- Check81 days agoChange DetectedRevision updated from v3.5.4 to v3.5.5 on the page, indicating a new version of the page layout or content. This is a system-level update and does not reflect changes to the study data or visible content, but may include minor fixes or enhancements to the page.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Unresectable Squamous Skin Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Unresectable Squamous Skin Cancer Clinical Trial page.